Physician profile
Alpha J Anders
NPI 1114032620
$9,966.00
in general payments reported to CMS, 2019-2025
19 companies · $591 in 2025
The $591 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $529 · 2020: $250 · 2021: $371 · 2022: $68.22 · 2023: $37.00 · 2024: $8,119 · 2025: $591.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $8,000 · Food and Beverage: $449 · Travel and Lodging: $298.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $8,000.00 |
| Food and Beverage | $449.04 |
| Travel and Lodging | $298.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $8,138.00 | 2024-2025 | Synchromedii |
| Abbott Laboratories | $483.41 | 2024-2025 | Proclaim, Eterna |
| Glaxosmithkline, LLC. | $468.82 | 2019-2022 | |
| Grifols USA, LLC | $178.75 | 2019-2020 | |
| Insmed, INC. | $157.39 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $151.99 | 2019-2022 | |
| Boston Scientific Corporation | $88.99 | 2025 | Intracept, Wavewriter Alpha Prime 16 |
| Advanced Respiratory, INC | $64.65 | 2019 | |
| Livanova USA, INC. | $37.00 | 2023 | Hemolung Cartridge Kit |
| Philips North America LLC | $31.21 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $24.64 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.18 | 2021 | |
| Sunovion Pharmaceuticals INC. | $21.27 | 2019 | |
| Genzyme Corporation | $19.34 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.28 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $18.20 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.76 | 2020 | |
| Csl Behring | $12.95 | 2019 | |
| Apria Healthcare LLC | $12.17 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alpha Anders listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.